BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 21, 2020
View Archived Issues
The world according to GARP
Read More
SGT-001 data support potential for treating Duchenne muscular dystrophy
Read More
Shorter telomere length tied to moderate to severe COPD
Read More
ViiV Healthcare patents new antivirals for HIV-1 infection
Read More
Topline phase I data and interim phase I/II results presented for Trappsol Cyclo in NPC1
Read More
CODA Biotherapeutics enters research collaboration with the FPRF
Read More
FDA approves IND application for phase III study of Octagam 10% in severe COVID-19 patients
Read More
Janssen Pharmaceutica discloses SGLT2 inhibitors
Read More
FDA clears IND application for FT-538
Read More
AiCuris identifies HBV capsid assembly inhibitors
Read More
MyoKardia synthesizes new cardiac myosin inhibitors
Read More
Targovax presents next-generation ONCOS virus, ONCOS-214
Read More
Novel mouse model for small cell carcinoma of bladder
Read More
Amygdala contains pain suppression circuit
Read More
Merck & Co. describes new SCN10A channel blockers
Read More
Antiviral Fc-conjugate CD-377 shows potent activity against influenza
Read More
CanSino initiates phase I trial of PCV13i vaccine
Read More
Administration of scAAV9.CLN8 shows promise for treating CLN8-driven Batten disease
Read More
Anavex receives Australian clearance for first-in-human study of ANAVEX 3-71
Read More
FDA clears Alethia's IND for phase II study of AB-16B5 in NSCLC
Read More
Topline phase IIb/III data reported for filgotinib in moderate to severely active ulcerative colitis
Read More
PDE2 plus PDE9 inhibition synergistically improves synaptic plasticity
Read More
